Basics BeiGene, Ltd. American Depositary Shares IPO Date: July 25, 2013 Sector: Healthcare Industry: Biotech Market Cap: $35.73B Activated in VL: True Average Daily Range Avg Daily Range: $3.96 | 1.45% Avg Daily Range (30 D): $6.08 | 1.80% Avg Daily Range (90 D): $4.64 | 1.42% Institutional Daily Volume Avg Daily Volume: .02M Avg Daily Volume (30 D): .25M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 36 Avg Trade Size (Sh.) (30 D): 23 Avg Trade Size (Sh.) (90 D): 29 Institutional Trades Total Inst.Trades: 363 Avg Inst. Trade: $6.65M Avg Inst. Trade (30 D): $5.59M Avg Inst. Trade (90 D): $6.43M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.74M Avg Closing Trade (30 D): $5.73M Avg Closing Trade (90 D): $6.38M Avg Closing Volume: 25.15K     News Dec 7, 2025 @ 11:03 PM BeOne Medicines Announced Sonrotoclax In Combinati... Source: Benzinga News Desk Nov 24, 2025 @ 11:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Zymeworks Inc. Nov 17, 2025 @ 5:09 PM Zymeworks, Jazz Pharmaceuticals Stocks Climb On Ro... Source: Vandana Singh Oct 31, 2025 @ 8:01 PM AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND Source: Prnewswire Oct 28, 2025 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Zymeworks Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $.09 $.07 $ Diluted EPS $.08 $.06 $ Revenue $ 1.41B $ 1.32B $ 1.12B Gross Profit $ 1.22B $ 1.15B $ 952.28M Net Income / Loss $ 124.84M $ 94.32M $ 1.27M Operating Income / Loss $ 163.11M $ 87.89M $ 11.1M Cost of Revenue $ 196.51M $ 164.61M $ 165M Net Cash Flow $ 1.32B $ 255.5M $ -108.16M PE Ratio 4,125.06